Cellular imaging in drug discovery
Related Experiment Video
Updated: Aug 9, 2026

Multiparametric Tumor Organoid Drug Screening Using Widefield Live-Cell Imaging for Bulk and Single-Organoid Analysis
Published on: December 23, 2022
Paul Lang1, Karen Yeow, Anthony Nichols
1Department of Molecular Screening & Cellular Pharmacology, Serono Pharmaceutical Research Institute, 14 chemin des Aulx, 1228 Plan-les-Ouates, Switzerland. Paul.Lang@serono.com
Abstract:
Traditional screening paradigms often focus on single targets. To facilitate drug discovery in the more complex physiological environment of a cell or organism, powerful cellular imaging systems have been developed. The emergence of these detection technologies allows the quantitative analysis of cellular events and visualization of relevant cellular phenotypes. Cellular imaging facilitates the integration of complex biology into the screening process, and addresses both high-content and high-throughput needs. This review describes how cellular imaging technologies contribute to the drug discovery process.

